Free Trial

Prime Medicine (PRME) SEC Filings & 10K Form

Prime Medicine logo
$1.46 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.49 +0.03 (+2.05%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Prime Medicine SEC Filings

DateFilerForm TypeView
06/12/2025
3:49 PM
Liu David R. (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
5:11 PM
Cahill Thomas (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
5:13 PM
Chung Wendy (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
5:13 PM
Foster-Cheek Kaye I (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
5:13 PM
Kelly Michael Aaron (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
5:13 PM
NELSEN ROBERT (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
5:13 PM
Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
5:14 PM
Prime Medicine (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:18 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:21 PM
LEE ANN L. (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:22 PM
Brudnick Richard (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
6:44 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
6:45 PM
Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:09 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
8:12 AM
Prime Medicine (Filer)
Form DEFA14A
05/12/2025
3:48 PM
LEE ANN L. (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
3:50 PM
Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
3:50 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:05 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:08 AM
Prime Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2025
5:19 AM
Prime Medicine (Filer)
Form ARS
04/22/2025
5:09 AM
Prime Medicine (Filer)
Form DEFA14A
04/22/2025
5:07 AM
Prime Medicine (Filer)
Form DEF 14A
03/18/2025
6:15 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
7:11 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:12 PM
Brudnick Richard (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:14 PM
LEE ANN L. (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:15 PM
Duffield Jeremy (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:16 PM
Goldwasser Meredith (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:18 PM
Alenson Carman (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
7:13 AM
Prime Medicine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2025
7:21 AM
Prime Medicine (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
7:02 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:01 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2024
11:15 PM
Prime Medicine (Filer)
Form EFFECT
12/13/2024
7:18 AM
Prime Medicine (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/09/2024
5:22 PM
Prime Medicine (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:22 PM
Brudnick Richard (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:23 PM
Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:32 PM
ARCH Venture Fund XII, L.P. (Filed by)
Prime Medicine (Subject)
Form SC 13D/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Prime Medicine (Subject)
Form SC 13G/A
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
10/24/2024
7:04 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:29 PM
Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:20 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Prime Medicine (Subject)
Form SC 13G
09/30/2024
6:38 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:26 AM
Prime Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:08 AM
Prime Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:PRME) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners